Market By Device Type And Country | Forecast 2021-2028
The Asia-Pacific peripheral vascular devices market is expected to progress with a CAGR of 12.46% by revenue over the estimated period from 2021 to 2028.
The countries studied in this market are:
•          China
•          Japan
•          India
•          Australia & New Zealand
•          South Korea
•          ASEAN countries
•          Rest of APAC countries
Diabetes is a very common condition in the Chinese population, and more than 10% of adults were reported to be suffering from it in 2017. China is estimated to have close to 183 million diabetics by 2045. The growing prevalence of this condition is expected to increase the rate of incidence of peripheral vascular disease as well. Further, the rapidly aging population is another factor leading to an enhanced occurrence of PVD. By the year 2026, China’s elderly population is estimated to grow and reach 200 million people. There were nearly 140 million people aged 65 years or above, and this population is expected to exceed over 200 million by 2026. People in this age group are highly vulnerable to diseases like PVD, and the growth in the geriatric populace will, in turn, raise the cases of the disease.
The above-stated factors like the growing prevalence of diabetes and the rising aging population are enhancing the demand for peripheral vascular devices. This growing demand will boost the peripheral vascular devices market growth in China in the coming years. Peripheral arterial disease (PAD) causes the narrowing of arteries apart from those associated with the brain and heart. As per a study published in Circulation Journal, there were close to 500,000 to 800,000 patients with atherosclerotic PAD in Japan in 2016. This high incidence rate of PAD has raised the demand for peripheral vascular devices. This is supporting the studied market growth in Japan.
Boston Scientific Corporation is a globally-renowned company developing, manufacturing, and marketing medical devices. The company’s products are used in a number of interventional medical specialties, such as interventional cardiology, interventional radiology, peripheral interventions, neurovascular intervention, neuromodulation, endoscopy, electrophysiology, vascular surgery, cardiac surgery, oncology, gynecology, and urology. Over the years, the company has built a strong brand portfolio and a reliable distribution network to cater to a major section of its potential market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET - SUMMARYÂ
2.   INDUSTRY OUTLOOK
2.1. KEY INSIGHTSÂ Â Â Â Â Â
2.1.1. SURGE IN THE ADOPTION OF VASCULAR PROCEDURESÂ Â Â Â Â Â Â Â Â Â
2.1.2. PRODUCT RECALLS OWING TO SAFETY CONCERNSÂ Â Â Â Â Â
2.2. IMPACT OF COVID-19 ON THE PERIPHERAL VASCULAR DEVICES MARKETÂ Â Â Â Â Â Â Â Â Â
2.3. PORTERS FIVE FORCES ANALYSISÂ
2.3.1. THREAT OF NEW ENTRANTSÂ Â Â Â
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERSÂ Â Â Â Â Â
2.3.5. THREAT OF COMPETITIVE RIVALRYÂ Â
2.4. MARKET ATTRACTIVENESS INDEXÂ Â
2.5. VENDOR SCORECARDÂ
2.6. KEY MARKET STRATEGIESÂ Â Â Â Â
2.6.1. MERGER & ACQUISITIONSÂ Â Â Â Â Â Â Â Â
2.6.2. PRODUCT LAUNCH & DEVELOPMENTSÂ Â Â Â Â Â Â Â
2.6.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATIONÂ Â
2.6.4. BUSINESS EXPANSIONÂ Â Â
2.7. MARKET DRIVERSÂ Â Â Â Â Â Â Â Â
2.7.1. MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASEÂ Â Â
2.7.2. PROLIFERATING INCIDENCE OF PERIPHERAL ARTERIAL DISEASEÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
2.7.3. CONTINUOUS TECHNOLOGICAL ADVANCEMENTS
2.8. MARKET CHALLENGES
2.8.1. STRINGENT REGULATORY PROCESS
2.8.2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICESÂ Â Â Â Â Â Â Â Â
2.8.3. INTENSE COMPETITIONÂ Â
2.9. MARKET OPPORTUNITIESÂ Â Â Â Â Â Â
2.9.1. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONSÂ Â Â Â Â Â Â Â Â Â
2.9.2. MARKET POTENTIAL IN DEVELOPING COUNTRIESÂ Â Â Â Â Â Â Â Â Â Â
3. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET OUTLOOK – BY DEVICE TYPE    Â
3.1. PERIPHERAL VASCULAR STENTSÂ Â Â Â
3.1.1. SELF-EXPANDING PERIPHERAL VASCULAR STENTSÂ Â Â Â Â Â
3.1.2. BALLOON-EXPANDING PERIPHERAL VASCULAR STENTSÂ Â Â Â Â Â Â Â Â Â
3.1.3. DRUG-ELUTING PERIPHERAL VASCULAR STENTS
3.1.4. COVERED STENTÂ Â
3.2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERSÂ
3.2.1. STANDARD PTA BALLOON CATHETERÂ Â Â Â Â Â Â Â Â Â
3.2.2. HIGH-PRESSURE PTA BALLOON CATHETERÂ Â Â Â Â Â Â Â Â Â Â
3.2.3. LARGE PTA BALLOON CATHETERÂ Â Â Â Â Â Â
3.2.4. SMALL PTA BALLOON CATHETERÂ Â Â Â Â Â Â
3.2.5. SPECIALTY PTA BALLOON CATHETERÂ Â Â Â Â Â Â Â Â Â
3.2.6. DRUG COATED PTA BALLOON CATHETERÂ Â Â
3.3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRESÂ Â Â Â Â Â Â Â
3.4. ATHERECTOMY DEVICESÂ Â Â Â Â Â Â Â
3.5. EMBOLIC PROTECTION DEVICESÂ Â Â Â Â
3.6. INFERIOR VENA CAVA FILTERSÂ Â Â Â Â Â Â Â Â
3.7. OTHER DEVICE TYPESÂ
4.   ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET – COUNTRY OUTLOOK         Â
4.1. CHINAÂ Â Â Â Â Â Â Â Â
4.2. JAPANÂ Â Â Â Â Â Â Â
4.3. INDIAÂ Â Â Â Â Â Â Â Â Â Â
4.4. SOUTH KOREAÂ Â Â Â
4.5. ASEAN COUNTRIESÂ Â Â Â Â Â Â
4.6. AUSTRALIA & NEW ZEALANDÂ
4.7. REST OF ASIA-PACIFIC
5.   COMPETITIVE LANDSCAPE
5.1. ABBOTT LABORATORIESÂ Â Â Â Â Â Â Â Â
5.2. ANGIOSCORE INC (SPECTRANETICS CORPORATION)Â Â
5.3. BOSTON SCIENTIFIC CORPORATIONÂ Â Â Â Â Â Â Â Â Â
5.4. BECTON DICKINSON AND COMPANYÂ Â Â Â Â Â Â Â Â Â
5.5. COOK GROUPÂ Â Â Â Â Â
5.6. CARDINAL HEALTH INC (CORDIS)Â Â Â Â Â
5.7. EDWARDS LIFESCIENCES CORPORATION
5.8. ENDOLOGIXÂ Â Â Â Â Â Â Â Â Â
5.9. KONINKLIJKE PHILIPS NVÂ Â Â Â Â Â Â Â
5.10. MEDTRONIC PLCÂ Â Â Â Â Â Â Â Â Â
5.11. TELEFLEX MEDICALÂ Â Â Â
5.12. TERUMO INTERVENTIONAL SYSTEMS INCÂ Â Â Â Â Â Â Â Â Â
6.   METHODOLOGY & SCOPE Â
6.1. RESEARCH SCOPE & DELIVERABLESÂ Â Â Â Â Â Â Â
6.2. SOURCES OF DATAÂ Â Â Â Â Â Â
6.3. RESEARCH METHODOLOGYÂ Â
TABLE 1: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF MERGER & ACQUISITIONS
TABLE 5: LIST OF PRODUCT LAUNCH & DEVELOPMENTS
TABLE 6: LIST OF PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
TABLE 7: LIST OF BUSINESS EXPANSION
TABLE 8: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, 2020 & 2028
FIGURE 3: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2020 & 2028
FIGURE 5: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SELF-EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON-EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG-ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2020 & 2028
FIGURE 11: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 23: CHINA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: JAPAN PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: INDIA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: SOUTH KOREA PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: ASEAN COUNTRIES PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: AUSTRALIA & NEW ZEALAND PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: REST OF ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET 2021-2028 (IN $ MILLION)